Key terms

About CVAC

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CVAC news

Today 7:51am ET Analysts Offer Insights on Healthcare Companies: CureVac (CVAC) and BioMarin Pharmaceutical (BMRN) by TipRanks Yesterday 5:30pm ET CureVac N.V. Reports Strong 2023 Finances and Strategic Advances by TipRanks Yesterday 5:29pm ET CureVac Launches Study for H5N1 Influenza Vaccine by TipRanks Yesterday 5:28pm ET CureVac Names New Chief Business Officer by TipRanks Yesterday 4:30pm ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Boston Scientific (BSX) and CureVac (CVAC) by TipRanks Yesterday 7:56am ET CureVac, GSK terminate Pandemic Preparedness Agreement by TipRanks Yesterday 7:55am ET CureVac implementing organizational redesign in 2024 by TipRanks Yesterday 7:55am ET CureVac reports Q4 revenue EUR 22.6M vs. EUR 11.7M last year by TipRanks Yesterday 7:31am ET CureVac names Thaminda Ramanayake chief business officer by TipRanks Yesterday 7:29am ET CureVac, GSK announce start of Phase 1 part of investigational H5N1 trial by TipRanks Yesterday 7:29am ET CureVac announces start of Phase 1/2 study in avian influenza by TipRanks Yesterday 7:28am ET CureVac appoints Thaminda Ramanayake as CBO by TipRanks Apr 18 12:29am ET CureVac (CVAC) Gets a Buy from Leerink Partners by TipRanks Apr 16 5:27pm ET CureVac Partners with MD Anderson on Cancer Vaccines by TipRanks Apr 16 7:25am ET CureVac, MD Anderson enter collaboration for cancer vaccines by TipRanks Apr 08 3:27am ET Leerink Partners Keeps Their Buy Rating on CureVac (CVAC) by TipRanks Apr 04 4:57pm ET CureVac’s Influenza Vaccine Shows Strong Phase 2 Results by TipRanks Apr 04 7:23am ET CureVac announces Phase 2 interim data from influenza vaccine program by TipRanks

No recent press releases are available for CVAC

CVAC Financials

1-year income & revenue

Key terms

CVAC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CVAC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Meta headquarters pictured on February 02, 2023 in Menlo Park, California.
Justin Sullivan/Getty Images
Meta’s stock plunges 15% on ‘aggressive’ AI spending plans
GettyImages-1159438448 copy.jpg
Lyndon Stratford/iStockphoto/Getty Images
Americans are falling behind on their payments
The logo of Swiss bank UBS is seen at the company's headquarters in Zurich, Switzerland February 10, 2015. REUTERS/Arnd Wiegmann/File Photo
Arnd Wiegmann/Reuters
Switzerland says UBS may need more cash. The bank is fuming
Jamie Dimon, Chairman and Chief Executive officer (CEO) of JPMorgan Chase & Co. (JPM) speaks to the Economic Club of New York in Manhattan in New York City, U.S., April 23, 2024. REUTERS/Mike Segar
Mike Segar/Reuters
Jamie Dimon fears for the future of the free world and US debt